News from roche canada A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Sep 24, 2020, 07:00 ET Health Canada Grants Market Authorization to Polivy™ (polatuzumab vedotin) for the treatment of adult patients with relapsed or refractory diffuse large B cell lymphoma[i]

First-in-class antibody-drug conjugate that specifically targets CD79b and destroys B cells through the delivery of an anti-cancer agent ii,iii MISSISSAUGA, ON, Sept. 24, 2020 /CNW/ - Hoffmann-La...

Aug 31, 2020, 08:00 ET Health Canada Authorizes ENSPRYNG® for Canadians Living with Neuromyelitis Optica Spectrum Disorder

ENSPRYNG is a targeted IL-6R treatment that is administered every four weeks by subcutaneous injection[1] MISSISSAUGA, ON, Aug. 31, 2020 /CNW/ - Hoffmann-La Roche Limited (Roche Canada) announced...

Jun 02, 2020, 07:00 ET Roche Canada Announces Winners of COVID-19 Open Innovation Challenge

Program will fund 11 unique solutions for challenges posed by COVID-19 from Canadians across the country MISSISSAUGA, ON, June 2, 2020 /CNW/ - Hoffmann-La Roche Limited (Roche Canada) is pleased to...

Apr 28, 2020, 08:00 ET Health Canada approves Rozlytrek® (entrectinib) for NTRK gene fusion-positive solid tumours in locally advanced or metastatic patients(1)

Data show more than half of trial patients across all 10 tumour types studied had responses to treatment,2 including in patients where cancer has spread to the central nervous system3 MISSISSAUGA,...

Apr 16, 2020, 07:00 ET Roche Canada Launches Data Science Coalition to Advance COVID-19 Solutions

Coalition created a publicly available centralized repository to enhance research MISSISSAUGA, ON, April 16, 2020 /CNW/ - Hoffmann-La Roche Limited (Roche Canada) is pleased to announce the launch of ...

Apr 08, 2020, 07:00 ET Roche Canada Launches Data Science Coalition to advance COVID-19 solutions

Coalition created a publicly available centralized repository to enhance research MISSISSAUGA, ON, April 8, 2020 /CNW/ - Hoffmann-La Roche Limited (Roche Canada) is pleased to announce the launch of...

Mar 31, 2020, 14:30 ET Roche Canada establishes COVID-19 Open Innovation Challenge

All Canadians invited to develop solutions for challenges posed by COVID-19 MISSISSAUGA, ON, March 31, 2020 /CNW/ - Hoffmann-La Roche Limited (Roche Canada) is pleased to announce the launch of the...

Nov 20, 2019, 09:51 ET New Report Reveals Major Gaps in Quality of Care for Canadians with Rare Lung Disease

Burden of Idiopathic Pulmonary Fibrosis in Canada report sheds light on barriers to treatment and resources for Canadians living with this debilitating condition MISSISSAUGA, ON, Nov. 20, 2019 /CNW/...

Aug 13, 2019, 08:00 ET Health Canada approves Tecentriq® (atezolizumab), first new treatment in 20 years for aggressive form of lung cancer(1)

Data show Tecentriq in combination with carboplatin and etoposide helped patients with extensive-stage small cell lung cancer live longer, with a 30% reduction in the risk of death2 MISSISSAUGA, ON,...

Jun 18, 2019, 07:59 ET Health Canada Approves Hemlibra® for Hemophilia A Patients Without Factor VIII Inhibitors

Hemlibra is the only treatment that can be self-injected subcutaneously once weekly for patients with hemophilia A without factor VIII inhibitors1 MISSISSAUGA, ON, June 18, 2019 /CNW/ - Hoffmann-La...

Mar 19, 2019, 10:00 ET Roche and the pan-Canadian Pharmaceutical Alliance (pCPA) Complete Negotiations for Multiple Sclerosis Treatment, OCREVUS® (ocrelizumab), for both RRMS and PPMS

MISSISSAUGA, ON, March 19, 2019 /CNW/ - Hoffmann-La Roche Limited (Roche Canada) today announced that it has completed negotiations with the pan-Canadian Pharmaceutical Alliance (pCPA) for a Letter...

Sep 13, 2018, 08:00 ET HERCEPTIN® (trastuzumab) subcutaneous (SC) formulation approved in Canada for the treatment of HER2-positive breast cancer

SC formulation takes two to five minutes to administer, rather than up to 90 minutes with the standard intravenous (IV) formulation MISSISSAUGA, ON, Sept. 13, 2018 /CNW/ - Hoffmann-La Roche Limited...

Aug 07, 2018, 08:00 ET Health Canada Approves HEMLIBRA® for Hemophilia A Patients with Inhibitors

HEMLIBRA is the first new treatment in almost 20 years for this most severe form of hemophilia1 and the only medicine that is self-injected once weekly MISSISSAUGA, ON, Aug. 7, 2018 /CNW/ -...

Aug 07, 2018, 08:00 ET Health Canada Approves HEMLIBRA® for Hemophilia A Patients with Inhibitors

HEMLIBRA is the first new treatment in almost 20 years for this most severe form of hemophilia1 and the only medicine that is self-injected once weekly MISSISSAUGA, ON, Aug. 7, 2018 /CNW/ -...

Jul 09, 2018, 08:00 ET Health Canada Approves GAZYVA® for Previously Untreated Advanced Follicular Lymphoma

GAZYVA is the first anti-CD20 treatment in 15 years for the most common subtype of indolent lymphoma.1 MISSISSAUGA, ON, July 9, 2018 /CNW/ - Hoffmann-La Roche Limited (Roche Canada) announced today...

Feb 15, 2018, 08:00 ET Health Canada Approves OCREVUS® (ocrelizumab) for Canadians Living with Primary Progressive Multiple Sclerosis (PPMS)

OCREVUS is a new treatment for a rare and worsening form of MS that impacts 10-15 per cent of Canadians living with the disease1 MISSISSAUGA, ON, Feb. 15, 2018 /CNW/ - Hoffmann-La Roche Limited...

Nov 02, 2017, 08:00 ET Health Canada Approves ACTEMRA® (tocilizumab) for Canadians Living with Giant Cell Arteritis (GCA)

ACTEMRA® is the first non-steroid treatment designed to directly target the interleukin-6 (IL-6) receptor, offering a new option to treat GCA1 MISSISSAUGA, ON, Nov. 2, 2017 /CNW/ - Hoffmann-La Roche...
Media Advisory/Photo Opportunity - Canadian Men's Relay Team Members Pass the Baton to Winnipeg to Fight IPF

Oct 24, 2017, 09:00 ET Media Advisory/Photo Opportunity - Canadian Men's Relay Team Members Pass the Baton to Winnipeg to Fight IPF

Join Olympian Aaron Brown as he raises awareness of this fatal lung condition WINNIPEG, Oct. 24, 2017 /CNW/ - One of Canada's fastest sprinters, Aaron Brown, will make his mark this Sunday, October...
MEDIA ADVISORY/PHOTO OPPORTUNITY: Canadian Men's Relay Team Members Pass the Baton to Vancouver to Fight IPF

Oct 12, 2017, 11:23 ET MEDIA ADVISORY/PHOTO OPPORTUNITY: Canadian Men's Relay Team Members Pass the Baton to Vancouver to Fight IPF

Join Aaron Brown and Brendon Rodney as they raise awareness of this fatal lung condition VANCOUVER, Oct. 12, 2017 /CNW/ - Two of Canada's fastest sprinters, Aaron Brown and Brendon Rodney will make...
Media Advisory/Photo Opportunity - Canadian Men's Relay Team Members Pass the Baton to Calgary to Fight IPF

Oct 05, 2017, 10:00 ET Media Advisory/Photo Opportunity - Canadian Men's Relay Team Members Pass the Baton to Calgary to Fight IPF

Join Akeem Haynes and Brendon Rodney as they raise awareness of this fatal lung condition CALGARY, Oct. 5, 2017 /CNW/ - Two of Canada's fastest sprinters, Akeem Haynes and Brendon Rodney will make...

Sep 20, 2017, 07:30 ET Andre De Grasse and the Canadian Men's Relay Team Pass the Baton to Help Canadians Fight Idiopathic Pulmonary Fibrosis (IPF)

Join the team as they raise awareness of this rare, but fatal, lung condition MISSISSAUGA, ON, Sept. 20, 2017 /CNW/ - This fall, as part of the Roche Fight IPF Six-Minute Marathons initiative,...

Aug 15, 2017, 08:00 ET Health Canada Approves OCREVUS™ (ocrelizumab) for Canadians Living with Relapsing-Remitting Multiple Sclerosis (RRMS)

OCREVUS is a first-in-class treatment that targets B-cells, offering a new pathway to treat MS1 MISSISSAUGA, ON, Aug. 15, 2017 /CNW/ - Hoffmann-La Roche Limited (Roche Canada) today announced that...

May 24, 2017, 17:03 ET Canadians with idiopathic pulmonary fibrosis participate in "six-minute marathon" to raise awareness of rare, but fatal lung disease(1)

Participants encourage others with the disease to learn more and stay active longer VICTORIA, May 24, 2017 /CNW/ - While many Canadians are lacing up their running shoes this spring to participate in ...
Princess Margaret Cancer Centre champions Canadian excellence in health research on Roche global cancer research network

Feb 14, 2017, 08:00 ET Princess Margaret Cancer Centre champions Canadian excellence in health research on Roche global cancer research network

Partnership positions Princess Margaret Cancer Centre to provide Canadian perspective on a Network of 21 academic centres from around the world to access and share technology, data and expertise to...

Feb 07, 2017, 07:30 ET Health Canada Approves GAZYVA® for Patients with Previously Treated Follicular Lymphoma

New targeted treatment now available for Canadians living with the most common form of slow-growing, non-Hodgkin's lymphoma MISSISSAUGA, ON, Feb. 7, 2017 /CNW/ - Hoffmann-La Roche Limited (Roche...